Trading Members of the Exchange are hereby informed that effective from August 16, 2021, the equity shares of Windlas Biotech Ltd (Scrip Code: 543329) are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. For further details please refer to the notice no 20210813-38 dated August 13, 2021.